Two new studies look at COVID-19 in young kids: one suggests routine vaccines may offer protection, while the other reviews several studies published on the topic from January to May.
looked at studies published between January 24 and May 14 of this year. It found that 19 percent of the pediatric population with COVID-19 had no symptoms; 21 percent had patchy lesions on lung x-rays; 5.6 percent suffered from co-infections, such as the flu, along with COVID-19; and 3.3 percent were admitted to intensive care units. The review also found that, in total, there were seven deaths reported.
When looking at symptoms, kids’ most frequent symptoms, similar to adults, were fever and cough, found in 59 percent and 56 percent, respectively, of the pediatric population. In 223 individuals, there was a previous medical history. In this group, 152 were kids with compromised immune systems or with underlying respiratory or cardiac disease. Plus, only a small number of patients were found to have symptoms consistent with multisystem inflammatory syndrome.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Rep. Kevin McCarthy on Covid-19 spikes, reopening the economy and moreRep. Kevin McCarthy (R—Calif.) joins 'Squawk Box' to discuss strategies for reopening the economy and whether there's a need for more legislation to get the economy moving again.
Read more »
COVID-19 drug remdesivir could cost $3,120 for some US patients
Read more »
Britain's COVID-19 app: The game changer that wasn'tAs Britain's COVID-19 infections soared in the spring, the government reached for what it hoped could be a game changer – a smartphone app that could automate some of the work of human contact tracers.
Read more »
Britain's COVID-19 app: The game changer that wasn'tAs Britain’s COVID-19 infections soared in the spring, the government reached for what it hoped could be a game changer – a smartphone app.
Read more »
Ex-Federal Health Officials Encourage Mask Use To Counter COVID-19 SurgesNPR's Steve Inskeep talks to Dr. Scott Gottlieb, who headed the FDA, and Andy Slavitt, who was the director of Medicare and Medicaid, about the spike in coronavirus cases across the country.
Read more »
Gilead prices COVID-19 drug candidate remdesivir at $2,340 per patientThe price tag is below the $5,080 per course recommendation by U.S. drug pricing research group, the Institute for Clinical and Economic Review (ICER), last week. Remdesivir is at the forefront of the fight against COVID-19 after the anti-viral treatment helped shorten hospital recovery times in a clinical
Read more »